Lotus Launches In Europe: Boston Scientific Joins Crowded TAVR Field
This article was originally published in The Gray Sheet
Executive Summary
The firm announced the CE mark and European launch of its transcatheter aortic heart valve replacement device Oct. 28. Boston is one of at least seven firms with a TAVR device now on the market in Europe.